nrt chart, page-2

Hi acouch,

nice charting software. What do you make out from the associated volume?

Price drivers to watch out for:

1) Patent announcement (granted Xmas eve)
2) NV-07a clinical trial completion
3) Phase II Phenoxodiol developments
4) Commencement of more Phase II trials
5) Commercialisation deal for the anti-ageing skin cream
6) Commencement of Phase Ib trials for the cardiovascular compound
7) Release of further stage I trial results, to date we've only seen the results of the low dose studies. The results with higher results have been held back pending publication in medical journals. I wonder why?
8) Release of further studies by medical institutions such as the Yale university research.
9) Commencement of trials with the new NV5063 specifically designed to kill breat cancer.
10) Possible finding of new compounds which are infinitely more potent than Phenoxodiol (as stated in the AGM)
11) Gaining more patents for the Soy Isoflavone business & subsequent royalties.

Happy New Year.